Richard Auburn
Direttore/Membro del Consiglio presso Singula Bio Ltd.
Posizioni attive di Richard Auburn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Oxford University Innovation Ltd.
 Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Investitore di Private Equity | 01/01/2015 | - |
Singula Bio Ltd.
 Singula Bio Ltd. BiotechnologyHealth Technology Singula Bio Ltd. is a seed-stage biotechnology company based in Oxford, UK. The British company was spun out of the University of Oxford and is focused on developing novel neoantigen-based cell therapies for patients with solid tumors. The company was founded by Vincenzo Cerundolo, Enda McVeigh, Ahmed Ahmed. | Direttore/Membro del Consiglio | 01/11/2020 | - |
Storia della carriera di Richard Auburn
Formazione di Richard Auburn
| University of Cambridge | Graduate Degree |
| University of Aberdeen | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 5 |
Posizioni
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
| Graduate Degree | 1 |
Settori
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Oxford University Innovation Ltd.
Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Finance |
Singula Bio Ltd.
Singula Bio Ltd. BiotechnologyHealth Technology Singula Bio Ltd. is a seed-stage biotechnology company based in Oxford, UK. The British company was spun out of the University of Oxford and is focused on developing novel neoantigen-based cell therapies for patients with solid tumors. The company was founded by Vincenzo Cerundolo, Enda McVeigh, Ahmed Ahmed. | Health Technology |
- Borsa valori
- Insiders
- Richard Auburn
- Esperienza
